Where Will Pharma Investments Head Next?
As India’s pharma sector shifts from a volume-driven generics model to an innovation-led ecosystem, its investment landscape is rapidly transforming. Ambitions to become a global innovation hub are pushing companies to rethink capital allocation, with R&D, manufacturing diversification, and digital transformation emerging as priorities.
Dr Vellaian Karuppiah | 03/12/2025 | By Akanki | 130
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy